| Obesity |
1 |
1 |
| Bariatric Surgery |
0 |
1 |
| Weight Loss |
0 |
0.61 |
| Weight Management |
0 |
0.56 |
| New York |
0 |
0.49 |
| Metabolism |
0 |
0.4 |
| Surgery |
0 |
0.4 |
| Laparoscopic Gastric Banding |
0 |
0.31 |
| Biliary Disease |
0 |
0.29 |
| Cerebrovascular Accident |
0 |
0.27 |
| Patient Safety |
0 |
0.12 |
| Body Mass Index |
0 |
0.09 |
| Endoscopy |
0 |
0.09 |
| Pain Management |
0 |
0.09 |
| Cardiovascular Risk Management |
0 |
0.08 |
| Postoperative Infection |
0 |
0.07 |
| Adverse Effects |
0 |
0.06 |
| Aspiration |
0 |
0.06 |
| Gastrectomy |
0 |
0.06 |
| Gastric Bypass |
0 |
0.06 |
| Heart |
0 |
0.06 |
| Postoperative |
0 |
0.06 |
| Socioeconomics |
0 |
0.06 |
| Abdominal Pain |
0 |
0.05 |
| Revenue and Practice Management |
0 |
0.05 |
| Social Determinants of Health |
0 |
0.05 |
| Abdomen |
0 |
0.03 |
| Adherence |
0 |
0.03 |
| Blood |
0 |
0.03 |
| Bowel Obstruction |
0 |
0.03 |
| Clinical Guidelines |
0 |
0.03 |
| Exercise |
0 |
0.03 |
| Fellowship |
0 |
0.03 |
| Gallstone |
0 |
0.03 |
| Hospital |
0 |
0.03 |
| Hypothalamus |
0 |
0.03 |
| Incretin Hormone |
0 |
0.03 |
| Insurance |
0 |
0.03 |
| LDL Cholesterol |
0 |
0.03 |
| Lipids Management |
0 |
0.03 |
| Malabsorption |
0 |
0.03 |
| Malnutrition |
0 |
0.03 |
| Multidisciplinary Team |
0 |
0.03 |
| Nausea |
0 |
0.03 |
| Nutrition |
0 |
0.03 |
| Pain |
0 |
0.03 |
| Perioperative Care |
0 |
0.03 |
| Primary Care |
0 |
0.03 |
| Professional Societies |
0 |
0.03 |
| Referral |
0 |
0.03 |
| Residency |
0 |
0.03 |
| Smoking |
0 |
0.03 |
| Stenosis |
0 |
0.03 |
| Tobacco Cessation |
0 |
0.03 |
| Tolerance |
0 |
0.03 |